ANGELA PAYTON: Open Payments
NPI 1144051368 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,216 in 58 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $405 · 2025 $1,216
Food & beverage: $1,216
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $384 |
| ABBVIE INC. | 19 | $273 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $183 |
| Gilead Sciences, Inc. | 5 | $98 |
| Lilly USA, LLC | 3 | $66 |
| QOL Medical, LLC | 3 | $58 |
| Ardelyx, Inc. | 3 | $57 |
| GENZYME CORPORATION | 1 | $24 |
| Aimmune Therapeutics, Inc. | 1 | $24 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
Products named: TREMFYA, ENTYVIO, RINVOQ, LINZESS, OMVOH, Sucraid, IBSRELA, CREON.
Industry payments across IN — which companies pay providers there.
